Collaboration with YZR Capital will aid apoQlar in improving its augmented reality technology. Credit: Bram Van Oost on Unsplash.

apoQlar has raised funds in a financing round led by YZR Capital, a German venture capital firm focusing on investments in the health tech field. 

The investment is said to confirm the potential of the augmented reality platform of apoQlar, VSI HoloMedicine. 

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

apoQlar expects the investment will help in the launch of its new software VSI HoloMedicine version 2.0, which could improve the planning of surgery, medical education and outcomes in patients.

Collaboration with YZR will aid apoQlar in improving its augmented reality technology, bolster its presence in the market and broaden its footprint globally. 

The latest funds will aid apoQlar in partnering with healthcare providers and surgical teams to boost surgical practices and patient outcomes.

See Also:

apoQlar CEO and co-founder Sirko Pelzl said: “This investment not only validates the potential of our augmented reality platform but also highlights the importance of our mission to improve surgical care. 

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We are confident in our ability to drive innovation, expand our reach, and make a significant impact on the healthcare industry globally.”

In Singapore, the company also entered a collaboration with National University Health System (NUHS), Infocomm Media Development Authority, Microsoft and Singtel to deploy the HoloMedicine ASAP architecture as part of the NUHS HoloMedicine Programme.